Skip to main content
Aidence logo

Aidence

Updated Mar 24, 2026

How Aidence stacks up in AI Healthcare — funding data, key investors, and more.

🇳🇱NetherlandsSeries BAI Healthcare

Out of 100

🇳🇱

HQ

Netherlands

🗓

Founded

2016

💰

Raised

$20M

🏷️

Stage

Series B

👥

Team

1-50

Aidence develops AI radiology software for lung cancer detection, building CE-marked and FDA-cleared deep learning algorithms that analyse CT scan images to identify and characterise pulmonary nodules requiring clinical follow-up. The Amsterdam company tools assist radiologists in national lung cancer screening programmes and in routine clinical CT reading, providing AI-generated nodule

Is this your company? Claim it →

Key Facts

  • Aidence has raised a total of $20M in disclosed funding across 3 funding rounds.
  • Aidence was founded in 2016 by Jeroen Vendrig and is headquartered in Netherlands.
  • Aidence employs approximately 1-50 people.
  • Aidence operates in the AI Healthcare category and is currently at the Series B stage.
  • Aidence has an Awaira Score of 45/100, ranking it among the tracked AI companies on Awaira.
  • Aidence's most recent funding round was a Series B of $14M closed in February 2019.

Source: Awaira · Updated Mar 24, 2026

N/A

Post-money

$20M

All rounds

45/100

2016

1-50 employees

Strengths

Growing team of 1-50 employees

Considerations

!

Valuation not publicly disclosed

Analysis based on publicly available data. Not investment advice.

3

Total Rounds

$6.67M

Avg Round Size

2.7yr

Funding Span

Aidence raised 3 rounds over 2.7 years, averaging $6.67M per round — a pace of roughly one round every 11 months.

⚠️ ESTIMATE
💵Est. Annual Revenue
$5M–$20M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does Aidence stack up against competitors?

MetricAidenceButterfly NetworkTempusAlan
Awaira Score45/10085/10084/10083/100
Total Raised$20M$370M$1.05B$750M
ValuationN/A$957M$8.1B$5.83B
StageSeries BPublicPublicSeries D
Founded2016201120152016
Employees1-50500-10002500500-1000
Country🇳🇱🇺🇸🇺🇸🇫🇷
J

Jeroen Vendrig

Founder & CEO

View founder profile →
StageSeries B
Employees1-50
Country🇳🇱 Netherlands
Connect
Inactive
3 rounds
Series BLatest

$14M

Feb 2019

Series A

$4.4M

Oct 2017

Seed

$1.6M

Jun 2016

Frequently Asked Questions

What is Aidence's valuation?
Valuation data is currently unavailable. The company may disclose this figure when it announces its next funding round.
Who invested in Aidence?
The investor base hasn't been publicly disclosed. The company may have institutional or angel backers that remain unnamed.
When did Aidence last raise funding?
The most recent round was a Series B of $14M, closed in February 2019.
How many employees does Aidence have?
Around 1-50 people work there, with headquarters in Netherlands.
What does Aidence do?
Aidence develops AI radiology software for lung cancer detection, building CE-marked and FDA-cleared deep learning algorithms that analyse CT scan images to identify and characterise pulmonary nodules requiring clinical follow-up. The Amsterdam company tools assist radiologists in national lung cancer screening programmes and in routine clinical CT reading, providing AI-generated nodule measurements, growth tracking, and malignancy risk scores that reduce reader variability and improve early detection rates. The company operates in the AI Healthcare sector from Netherlands.
Who founded Aidence?
The company was started by Jeroen Vendrig in 2016 in Netherlands. Jeroen Vendrig serves as Founder & CEO.
Is Aidence profitable?
Whether the company is profitable hasn't been confirmed publicly. It has raised $20M in total funding and is classified at the Series B stage.
Where is Aidence headquartered?
Home base is Netherlands 🇳🇱. The AI Healthcare company was founded in 2016 and operates from there.
⚔️

Compare Aidence

See how Aidence stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →